Nr 546 week 8 alzheimers - Study guides, Class notes & Summaries
Looking for the best study guides, study notes and summaries about Nr 546 week 8 alzheimers? On this page you'll find 12 study documents about Nr 546 week 8 alzheimers.
All 12 results
Sort by
-
NR 546 WEEK 8 ALZHEIMER’S DISEASE (AD) EXAM QUIZ QUESTIONS WITH DETAILED CORRECT ANSWERS 2025| VERIFIED ANSWERS
- Exam (elaborations) • 8 pages • 2024
-
- $17.99
- + learn more
NR 546 WEEK 8 ALZHEIMER’S DISEASE 
(AD) EXAM QUIZ QUESTIONS WITH 
DETAILED CORRECT ANSWERS 2025| 
VERIFIED ANSWERS
-
NR 546 Week 8 Dementia Medication Table Latest Update 2024 A+.
- Exam (elaborations) • 5 pages • 2024
-
- $11.49
- + learn more
NR 546 Week 8 Dementia Medication Table Latest Update 2024 A+. 
Drug Name and Class FDA Indication (include 
stages ) 
Neurotransmitters 
Affected/Mechanism of 
Action 
Target Symptoms 
Short-acting, 
intermediate-acting, or 
long-acting. 
Duration of Action and 
Half-life (T1/2), 
CYP 450 enzyme 
Notable Side Effects/Precautions /Patient Education 
Instructions 
Donepezil (Aricept) Alzheimer’s disease – mild, 
moderate, and severe 
Acetylcholine enzyme 
inhibitor 
Reversibly but 
noncompeti...
-
NR 546 Week 8 Dementia Medication Table Latest Update 2024 A+.
- Exam (elaborations) • 5 pages • 2024
-
- $12.99
- + learn more
NR 546 Week 8 Dementia Medication Table Latest Update 2024 A+. 
Drug Name and Class FDA Indication (include 
stages ) 
Neurotransmitters 
Affected/Mechanism of 
Action 
Target Symptoms 
Short-acting, 
intermediate-acting, or 
long-acting. 
Duration of Action and 
Half-life (T1/2), 
CYP 450 enzyme 
Notable Side Effects/Precautions /Patient Education 
Instructions 
Donepezil (Aricept) Alzheimer’s disease – mild, 
moderate, and severe 
Acetylcholine enzyme 
inhibitor 
Reversibly but 
noncompeti...
-
NR 546 Week 8 Dementia Medication Table Latest Update 2024 A+.
- Exam (elaborations) • 5 pages • 2024
-
- $10.99
- + learn more
NR 546 Week 8 Dementia Medication Table Latest Update 2024 A+. 
Drug Name and Class FDA Indication (include 
stages ) 
Neurotransmitters 
Affected/Mechanism of 
Action 
Target Symptoms 
Short-acting, 
intermediate-acting, or 
long-acting. 
Duration of Action and 
Half-life (T1/2), 
CYP 450 enzyme 
Notable Side Effects/Precautions /Patient Education 
Instructions 
Donepezil (Aricept) Alzheimer’s disease – mild, 
moderate, and severe 
Acetylcholine enzyme 
inhibitor 
Reversibly but 
noncompeti...
-
NR 546 WEEK 8 - ALZHEIMER'S DISEASE 2024 EXAM QUIZ QUESTIONS WITH DETAILED CORRECT ANSWERS | VERIFIED ANSWERS
- Exam (elaborations) • 16 pages • 2024
-
Available in package deal
-
- $19.99
- + learn more
NR 546 WEEK 8 2024 EXAM QUIZ 
QUESTIONS WITH DETAILED 
CORRECT ANSWERS | VERIFIED 
ANSWERS
Want to regain your expenses?
-
NR 546 Week 8 Dementia Medication Tabl e / Dementia medication table LATEST UP DATE 2024 GRADED A+
- Exam (elaborations) • 7 pages • 2024
-
- $11.49
- + learn more
NR 546 Week 8 Dementia Medication Tabl 
e / Dementia medication table LATEST UP 
DATE 2024 GRADED A+ 
Drug Name and Class FDA Indication (include 
stages ) 
Neurotransmitters 
Affected/Mechanism of 
Action 
Target Symptoms 
Short-acting, 
intermediate-acting, or 
long-acting. 
Duration of Action and 
Half-life (T1/2), 
CYP 450 enzyme 
Notable Side Effects/Precautions /Patient Education 
Instructions 
Donepezil (Aricept) Alzheimer’s disease – mild, 
moderate, and severe 
Acetylcholine enzyme ...
-
NR 546 Week 8 Dementia Medication Tabl e / Dementia medication table LATEST UP DATE 2024 GRADED A+
- Exam (elaborations) • 7 pages • 2024
-
- $12.49
- + learn more
NR 546 Week 8 Dementia Medication Tabl 
e / Dementia medication table LATEST UP 
DATE 2024 GRADED A+ 
Drug Name and Class FDA Indication (include 
stages ) 
Neurotransmitters 
Affected/Mechanism of 
Action 
Target Symptoms 
Short-acting, 
intermediate-acting, or 
long-acting. 
Duration of Action and 
Half-life (T1/2), 
CYP 450 enzyme 
Notable Side Effects/Precautions /Patient Education 
Instructions 
Donepezil (Aricept) Alzheimer’s disease – mild, 
moderate, and severe 
Acetylcholine enzyme ...
-
NR 546 Week 8 Dementia Medication Tabl e / Dementia medication table LATEST UP DATE 2024 GRADED A+
- Exam (elaborations) • 7 pages • 2024
-
- $13.99
- + learn more
NR 546 Week 8 Dementia Medication Tabl 
e / Dementia medication table LATEST UP 
DATE 2024 GRADED A+ 
Drug Name and Class 
FDA Indication (include stages ) 
Neurotransmitters Affected/Mechanism of Action 
Target Symptoms 
Short-acting, intermediate-acting, or long-acting. 
Duration of Action and Half-life (T1/2), 
CYP 450 enzyme 
Notable Side Effects/Precautions /Patient Education Instructions 
Donepezil (Aricept) 
Alzheimer’s disease – mild, moderate, and severe 
Acetylcholine enzyme inhibi...
-
NR 546 Week 8 Dementia Medication Tabl e / Dementia medication table LATEST UP DATE 2024 GRADED A+ Drug Name and Class FDA Indication (include stages ) Neurotransmitters Affected/Mechanism of Action Target Symptoms Short-acting, intermediate-acting, or
- Exam (elaborations) • 7 pages • 2024
-
- $10.99
- + learn more
NR 546 Week 8 Dementia Medication Tabl 
e / Dementia medication table LATEST UP 
DATE 2024 GRADED A+ 
Drug Name and Class FDA Indication (include 
stages ) 
Neurotransmitters 
Affected/Mechanism of 
Action 
Target Symptoms 
Short-acting, 
intermediate-acting, or 
long-acting. 
Duration of Action and 
Half-life (T1/2), 
CYP 450 enzyme 
Notable Side Effects/Precautions /Patient Education 
Instructions 
Donepezil (Aricept) Alzheimer’s disease – mild, 
moderate, and severe 
Acetylcholin...
-
2024 NR 546 WEEK 8 EXAM WITH CORRECT ANSWERS
- Exam (elaborations) • 6 pages • 2024
-
Available in package deal
-
- $13.99
- + learn more
2024 NR 546 WEEK 8 EXAM WITH CORRECT ANSWERS
How much did you already spend on Stuvia? Imagine there are plenty more of you out there paying for study notes, but this time YOU are the seller. Ka-ching! Discover all about earning on Stuvia